Stay updated on Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details for the IMMUNEBOOST study of neoadjuvant nivolumab for high-risk HPV-driven oropharynx cancer, including its completed status, treatment arms, eligibility criteria, outcomes, and study locations.
    Difference
    59%
    Check dated 2026-11-07T11:07:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T09:57:36.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T10:46:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T12:59:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:28:42.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message with a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-03T13:49:11.000Z thumbnail image

Stay in the know with updates to Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.